A multi-center observational study on the Prevalence of Loss of benefit after DBS for medication-refractory tremor
- Conditions
- shakingtremor10028037
- Registration Number
- NL-OMON51271
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 20
1. Patients of any age over 18 who are capable of understanding and granting
informed consent.
2. Patients who have undergone unilateral or bilateral DBS surgery for
medication-refractory upper extremity tremor at least 5 years prior to
recruitment. The upper limit for the time since surgery will be 15 years. Long
intervals are specifically welcome.
3. Preoperative diagnosis of ET, ET plus or isolated dystonic tremor as defined
by the tremor task force of the international Parkinson and Movement Disorders
Society consensus in 2018 (Bhatia et al., 2018).
4. Availability of retrospective clinical baseline and early postoperative
data, including tremor scales (see below 4.3.4).
5. Stable tremor medications and stimulation settings for at least 2 months
prior to the study visit.
6. Patients must be able to follow the assessment procedure.
1. Concomitant diseases that may confound the neurological findings.
2. DBS hardware malfunction (e.g., battery or electrode failure).
3. Significant cognitive impairment that may make patient unable to follow
assessment procedure.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary outcome variables: Loss of benefit and categorical loss of benefit.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary outcome variables: Rebound tremor and overshoot benefit.</p><br>